Workshop on the Treatment of Pulmonary Embolism-Which Patients Do I Choose for Systemic Lysis? Dr. Joshua Beckman

Which Patients Do I Choose for Systemic Lysis? Dr. Joshua Beckman

Video Transcription

Video Summary

The speaker discusses systemic thrombolysis, emphasizing its evidence base and appropriate usage. The PYTHO trial, a significant study, highlighted benefits like hemodynamic stability but not reduced mortality. The discussion covers the risks, emphasizing careful selection, especially in patients over 65 due to higher bleeding risk. In high-risk pulmonary embolism (PE) cases, systemic thrombolysis is standard, but catheter-directed approaches are gaining attention for potentially safer outcomes. The speaker personally uses systemic thrombolysis in urgent scenarios where immediate intervention is necessary, indicating the evolving clinical landscape with emerging treatment options.

Keywords

systemic thrombolysis

PYTHO trial

pulmonary embolism

hemodynamic stability

catheter-directed approaches